October 18, 2018
PCSK9 inhibitors, a new class of drugs that help reduce cholesterol levels, can be life-saving for some patients—but many do not have access to the drugs because of their extremely high prices.
October 17, 2018
From politics to financial concerns, Robert Pearl, a surgeon and former CEO of the Permanente Medical Group, in a Forbes article breaks down the "five intense fears" plaguing doctors today.
October 16, 2018
CMS under a newly proposed rule would require prescription drugmakers to include their products' list prices in direct-to-consumer television advertisements, but Pharmaceutical Research and Manufacturers of America says the proposed rule raises legal questions, and its members instead will direct consumers to company websites with pricing information for their products.
Many supplements marketed for muscle growth, sexual enhancement, and weight loss contain unapproved or recalled pharmaceuticals that have "the potential to cause serious adverse health effects," according to a new study.
October 10, 2018
The Department of Justice will allow CVS Health and health insurer Aetna to move forward with their merger provided Aetna divests its Medicare Part D business.
A new study finds patients give higher ratings to doctors who prescribe antibiotics for a common cold—even if they do not need the drugs.
October 8, 2018
Supreme Court Justice Brett Kavanaugh has ruled on several high-profile health care cases that some observers say could shed light on how he would rule if cases on those issues were to reach the Supreme Court.
October 5, 2018
American Health Line rounds up the latest health care news in the states.
October 4, 2018
The 660-page legislative package seeks to address the opioid epidemic through a variety of public health initiatives to expand access to treatments for opioid use disorders, promote the development of alternative treatments for pain, and prevent the entry of illicit drugs into the United States.
Dozens of patients in Texas are taking legal action after receiving a botched compounded injectable eye drug that left them partially blind—a case that observers say highlights the holes in regulatory oversight of compounding pharmacies.
The Advisory Board Company. All Rights Reserved.